Lille Cedex

• A Study of Subcutaneous Nivolumab + Relatlimab FDC in Previously Untreated Metastatic or Unresectable Melanoma (RELATIVITY-127) Recruiting
  2022-500967-11-00 5 2023-07-06 Previously Untreated Metastatic or Unresectable Melanoma
• Benefit of transplantation after Complete Response In Patients with T-cell lymphoma Recruiting
  2022-501710-62-02 6 2023-06-07 Peripheral T-cell lymphoma (PTCL)
• A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX- 880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaire … Recruiting
  2024-513929-23-00 10 2023-05-26 Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Seve
• Evaluation of diagnostic performances of 18F-FDOPA PET KInetics as biomarkers for the improvement of care of MRI Non-contrast enhanced Gliom … Recruiting
  2022-501688-42-00 5 2023-05-24 Low Grade Glioma
• RIISC Recruiting
  2024-513669-38-00 5 2023-05-17 Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial In
• First-in-human study of OT-A201 in patients with selected hematological malignancies and solid tumors Recruiting
  2024-511936-28-00 1 2023-05-12 Relapsed/refractory hematological malignancies or advanced/metastatic
• A Phase 1 Study to Determine the Safety, and Pharmacokinetics of the Selective MET kinase Inhibitor, DO-2 in Patients With Advanced or Refra … Recruiting
  2023-504897-39-00 1 2023-04-13 Advanced or refractory solid tumours (Part 1)
• PREPARE - Intrapapillary botulinum toxin injection for PREvention of post-surgical PAncREatic fistula Recruiting
  2024-514929-33-00 5 2023-03-27 PANCREATIC FISTULA
• Piperacillin-tazobactam and temocillin as carbapenem-alternatives for the treatment of severe infections due to extended-spectrum beta-lacta … Recruiting
  2024-511866-36-00 5 2023-03-11 patients hospitalized in ICU with ESBL-producing Enterobacteriaceae se
• A RANDOMIZED DOUBLE BLIND, PLACEBO-CONTROLLED NATIONAL MULTICENTER PHASE 3 TRIAL TO EVALUATE THE EFFICACY OF AZATHIOPRINE FOR THE PREVENTION … Recruiting
  2022-500520-30-00 5 2023-03-01 neurology
• Randomized prospective trial evaluating the efficacy of the antiCD38 monoclonal antibody isatuximab in the treatment of PCRA by major ABO mi … Recruiting
  2024-514351-14-00 4 2023-02-20 Pure cell red aplasia by major ABO mismatch after allogeneic hematopoi
• Chemotherapy for the treatment of standard risk adult medulloblastomas Recruiting
  2024-513243-85-00 4 2023-02-03 Adult medulloblastoma
• EvER-ILD 2: Evaluation of Efficacy and safety of Rituximab in patients with progressive Interstitial Lung Disease (ILD) with inflammatory co … Recruiting
  2022-501335-16-00 10 2023-01-16 Interstitial lung disease
• Early discontinuation of steroid treatment in negative FDG-PET/CT patients with idiopathic retroperitoneal fibrosis Recruiting
  2024-514353-30-00 6 2022-11-25 Idiopathic retroperitoneal fibrosis
• A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neu … Recruiting
  2024-510990-21-00 10 2022-11-11 Mucopolysaccharidosis Type II [MPS II]
• Evaluation of the efficacy and safety of alpelisib (BYL719) in pediatric and adult patients with Megalencephaly-CApillary malformation Polym … Recruiting
  2022-500197-34-01 4 2022-11-03 Megalencephaly-CApillary malformation Polymicrogyria syndrome
• Study to determine the dose and safety of asciminib in pediatric patients with chronic myeloid leukemia. Recruiting
  2023-508129-28-00 9 2022-09-28 Pediatric patients with Philadelphia chromosome positive chronic myelo
• Combination lock01 - Impact of aminoglycosides-based antibiotics combination and protective isolation on outcomes in critically-ill neutrope … Recruiting
  2024-514042-36-00 5 2022-09-21 Adult patients admitted to intensive care
• CPX-351 versus intensive chemotherapy in patients with de novo intermediate or adverse risk AML stratified by genomics Recruiting
  2022-500295-60-00 4 2022-09-15 Acute Myeloid Leukemia
• Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel Recruiting
  2023-505530-10-00 6 2022-09-14 Multiple Myeloma
• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Dia … Recruiting
  2023-510384-36-00 5 2022-09-13 Newly Diagnosed Multiple Myeloma
• Venetoclax in children with relapsed AML Recruiting
  2023-510160-12-00 5 2022-08-16 acute myeloid leukemia
• A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia Recruiting
  2023-503335-18-00 1 2022-07-29 Chronic myeloid leukemia
• A randomized phase I/ II multicenter study evaluating combination of luspatercept in LR-MDS without RS having failed or being ineligible to … Recruiting
  2024-515354-24-00 9 2022-05-18 Low risk myelodysplastic syndrom without RS having failed or being ine

Showing 313–336 of 688 trials